Stigma Associated with a High-Risk State for Psychosis
与精神病高风险状态相关的耻辱
基本信息
- 批准号:8644936
- 负责人:
- 金额:$ 49.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-22 至 2017-03-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAddressAdolescent and Young AdultAdultAffectAttitudeBehaviorBenchmarkingClinical ResearchCosts and BenefitsCountryDataDevelopmentDiagnosisDiagnostic and Statistical Manual of Mental DisordersEarly DiagnosisEarly identificationFamilyFamily memberGoalsHospitalizationIndividualInterventionInvestigationLifeMeasuresOutcomePerceptionPhasePoliciesPsychotic DisordersRecoveryRelative (related person)ResearchResearch PersonnelRiskSchizoaffective DisordersSchizophreniaSchoolsSeveritiesSocial FunctioningSocial NetworkSourceStagingSymptomsTimecomparison groupexperiencefollow-uphigh riskpeerpreventpsychologicpsychological outcomesresponsesocialsocial stigmatreatment adherence
项目摘要
PROJECT SUMMARY
We propose the first study to systematically examine any potential effects of stigma associated with the new
'high risk for psychosis' ('HRP') designation, a groundbreaking development in the earliest identification of
psychotic signs that enables efforts to prevent psychosis. Concerns of stigma towards the new HRP status
have been expressed because this designation has the potential to activate the same severe social
ramifications known to be associated with an identification of 'psychosis'. Stigma may be an unnecessary risk
especially because the majority of those identified as HRP even in the absence of intervention do not go on to
develop psychosis. Further, the HRP designation is being used in over 6 countries (including the U.S.) and
there is current debate to include it officially within the DSM 5 in 2013. Because no evidence exists regarding
stigma of the HRP, we bring together expertise from two well-established research teams that have experience
in treating and following HRP individuals and their family members with that of recognized researchers in
stigma and the early course of psychosis. We propose a comprehensive approach to assessing stigma
experiences among a HRP group (n= 196) and associated 'family attitudes' among family members (n= 155) at
initial HRP identification and then at 6 months follow-up. We compare the stigma experiences of the HRP
group with that of a first episode non-affective psychosis group (FEP; n= 100) who act as a benchmark for
severe stigma. We examine stigma of the HRP designation at baseline, how any stigma may increase or
decrease over time, and how this stigma compares with that of an FEP group. We further assess longitudinal
impacts of HRP stigma and 'family attitudes' upon changes in psychological, social, and developmental
outcomes in the HRP group. This research promises to greatly inform interventions to counter stigma at its
earliest stages and maximize opportunities for people at HRP to attain developmental goals leading to
adulthood. Further, removing or ameliorating this concern of stigma is crucial, as HRP identification is a
potentially transformative means of preventing and treating schizophrenia, thus reducing burden for
psychosis worldwide.
项目摘要
我们提出了第一项研究,系统地检查与新的歧视相关的任何潜在影响。
“精神病高危”(“HRP”)的认定,这是最早识别精神病的一个突破性发展。
使人们能够努力预防精神病的精神病症状。对新HRP地位的耻辱感的担忧
已经表达,因为这种指定有可能激活同样严重的社会问题,
已知与“精神病”的鉴定有关的后果。污名化可能是不必要的风险
特别是因为大多数被确定为HRP的人即使在没有干预的情况下也不会继续
发展成精神病此外,HRP名称已在超过6个国家(包括美国)使用。和
目前正在讨论是否在2013年将其正式纳入DSM 5。因为没有证据表明
HRP的耻辱,我们汇集了两个成熟的研究团队的专业知识,
在治疗和以下HRP个人和他们的家庭成员与公认的研究人员,
耻辱感和精神病的早期病程。我们提出了一个全面的方法来评估耻辱
HRP组(n= 196)的经验和家庭成员(n= 155)的相关“家庭态度”,
初始HRP鉴定,然后在6个月随访时。我们比较了HRP的污名体验
组与首次发作非情感性精神病组(FEP; n= 100),作为基准,
严重的耻辱。我们检查了HRP指定在基线的耻辱,如何任何耻辱可能会增加,
随着时间的推移而减少,以及这种耻辱与FEP组相比如何。我们进一步评估纵向
HRP污名和“家庭态度”对心理、社会和发展变化的影响
HRP组的结果。这项研究有望为干预措施提供大量信息,
最早的阶段,最大限度地提高HRP人员实现发展目标的机会,
成年此外,消除或改善这种耻辱感是至关重要的,因为HRP鉴定是一种有效的方法。
预防和治疗精神分裂症的潜在变革性手段,从而减轻
精神病世界
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAWRENCE H YANG其他文献
LAWRENCE H YANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAWRENCE H YANG', 18)}}的其他基金
RCT of an intersectional stigma intervention to sustain viral suppression among women living with serious mental illness and HIV in Botswana
对博茨瓦纳患有严重精神疾病和艾滋病毒的妇女进行交叉污名干预以维持病毒抑制的随机对照试验
- 批准号:
10650820 - 财政年份:2022
- 资助金额:
$ 49.09万 - 项目类别:
RCT of an intersectional stigma intervention to sustain viral suppression among women living with serious mental illness and HIV in Botswana
对博茨瓦纳患有严重精神疾病和艾滋病毒的妇女进行交叉污名干预以维持病毒抑制的随机对照试验
- 批准号:
10925898 - 财政年份:2022
- 资助金额:
$ 49.09万 - 项目类别:
RCT of an intersectional stigma intervention to sustain viral suppression among women living with serious mental illness and HIV in Botswana
对博茨瓦纳患有严重精神疾病和艾滋病毒的妇女进行交叉污名干预以维持病毒抑制的随机对照试验
- 批准号:
10542992 - 财政年份:2022
- 资助金额:
$ 49.09万 - 项目类别:
Stigma Associated with a High-Risk State for Psychosis
与精神病高风险状态相关的耻辱
- 批准号:
8222135 - 财政年份:2012
- 资助金额:
$ 49.09万 - 项目类别:
Stigma Associated with a High-Risk State for Psychosis
与精神病高风险状态相关的耻辱
- 批准号:
8827420 - 财政年份:2012
- 资助金额:
$ 49.09万 - 项目类别:
Stigma Associated with a High-Risk State for Psychosis
与精神病高风险状态相关的耻辱
- 批准号:
8472539 - 财政年份:2012
- 资助金额:
$ 49.09万 - 项目类别:
Examining Deficit Syndrome in an Untreated, Representative SCZ Cohort in China
检查中国未经治疗的代表性 SCZ 队列中的缺陷综合症
- 批准号:
8311054 - 财政年份:2011
- 资助金额:
$ 49.09万 - 项目类别:
Examining the Deficit Syndrome Subtype in an Untreated and Treated Non-Acute, Rep
检查未经治疗和治疗的非急性、代表的缺陷综合症亚型
- 批准号:
8178762 - 财政年份:2011
- 资助金额:
$ 49.09万 - 项目类别:
Expressed Emotion and Stigma among Chinese-Americans with Schizophrenia
患有精神分裂症的华裔美国人的情感表达和耻辱感
- 批准号:
7364653 - 财政年份:2005
- 资助金额:
$ 49.09万 - 项目类别:
Expressed Emotion and Stigma among Chinese-Americans with Schizophrenia
患有精神分裂症的华裔美国人的情感表达和耻辱感
- 批准号:
7616463 - 财政年份:2005
- 资助金额:
$ 49.09万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 49.09万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 49.09万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 49.09万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 49.09万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 49.09万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 49.09万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 49.09万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 49.09万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 49.09万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 49.09万 - 项目类别:
Research Grant